Recent data pointed out that CD40 presents good discriminatory properties for cervical cancer, where secreted CD40 exhibits high sensitivity and specificity, making this protein an interesting target for immunotherapy combined with radiation (29). This evidence concerns the gene CD40 and cervical carcinoma.